Status:
COMPLETED
a/LCI-OCT Pilot in Esophagus
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Cancer Institute (NCI)
University of North Carolina, Chapel Hill
Conditions:
Barrett Esophagus
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study will test a newly developed dual modality probe, including optical coherence tomography (OCT) and angle-resolved low-coherence interferometry (a/LCI), in the human esophagus to determine 1)...
Eligibility Criteria
Inclusion
- Presenting to University of North Carolina (UNC) for routine care upper endoscopy
- Meet one of the following criteria:
- Current dysplastic or non-dysplastic Barrett's Esophagus of any length OR,
- History of dysplastic or non-dysplastic Barrett's Esophagus after treatment with endoscopic eradication therapy (EET) OR,
- Normal asymptomatic controls without any history of dysplastic Barrett's Esophagus
- Aged 18 to 80
- Able to read, comprehend, and understand the informed consent document
Exclusion
- Prior esophageal surgery (uncomplicated nissen fundoplication OK)
- Pregnant women
- Unable to provide written informed consent
Key Trial Info
Start Date :
November 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 29 2022
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT04392167
Start Date
November 24 2020
End Date
November 29 2022
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599